Safety research
Melanotan II Side Effects — Research Findings
Side effect profiles documented in published Melanotan II research depend on dose, route of administration, and model system. The following are commonly reported findings from research literature — not from personal use contexts.
- Mild nasal irritation when intranasal routes used in published Semax/Selank research
- Injection site reactions for subcutaneous administration routes
- Generally well-tolerated in nootropic peptide literature at research doses
- No significant dependence or withdrawal reported in animal model studies



